Phthalic Acid

Phthalic Acid

SCHEMBL7129666

CCCCC(C)CC.CCCCC(C)CC.O=C(O)c1ccccc1C(=O)O

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.56
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
KDM4E B2RXH2 1/20 0.50
RECQL P46063 1/20 0.50
CA2 P00918 1/20 0.49
CYP3A4 P08684 1/20 0.49
ALOX15 P16050 1/20 0.48
TSHR P16473 3/20 0.47
POLB P06746 2/20 0.45
LMNA P02545 1/20 0.44
CA12 O43570 2/20 0.44
CA9 Q16790 2/20 0.44
PRSS1 P07477 1/20 0.43
PRSS2 P07478 1/20 0.43
PRSS3 P35030 1/20 0.43
CNR2 P34972 1/20 0.43
MAPT P10636 1/20 0.42
MAPK1 P28482 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Salicylic Acid SCHEMBL6132155 0.91 ALDH1A1 (0.55) ALDH1A1MEN1KMT2AKDM4ERECQL
SCHEMBL27686387 0.87 ALDH1A1 (0.45) ALDH1A1MEN1KMT2AKDM4ERECQL
Phthalic Acid SCHEMBL81278 0.86 ALDH1A1 (0.68) ALDH1A1MEN1KMT2AKDM4ERECQL
Phthalic Acid SCHEMBL28780791 0.85 ALDH1A1 (0.62) ALDH1A1MEN1KMT2AKDM4ERECQL
Phthalic Acid SCHEMBL28573360 0.85 ALDH1A1 (0.62) ALDH1A1MEN1KMT2AKDM4ERECQL
Phthalic Acid SCHEMBL27814094 0.83 ALDH1A1 (0.56) ALDH1A1MEN1KMT2AKDM4ERECQL
Phthalic Acid SCHEMBL29900353 0.82 ALDH1A1 (0.55) ALDH1A1MEN1KMT2AKDM4ERECQL
Phthalic Acid SCHEMBL8576272 0.82 ALDH1A1 (0.55) ALDH1A1MEN1KMT2AKDM4ERECQL
SCHEMBL19690526 0.82 ALDH1A1 (0.63) ALDH1A1MEN1KMT2AKDM4ERECQL
Phthalic Acid SCHEMBL27649796 0.81 CA2 (0.67) ALDH1A1MEN1KMT2AKDM4ERECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130252924-A1 Compounds and Methods for Treating Pain AKRON MOLECULES GMBH (AT) 2013-09-26 US disclosed
JP-2003287495-A METHOD FOR QUANTITATIVELY DETERMINING ENDOCRINE DISRUPTOR NATIONAL INSTITUTE OF AGROBIOLOGICAL SCIENCES 2003-10-10 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130252924-A1 Compounds and Methods for Treating Pain TRPV1, ACHE, OPRL1 ALDH1A1 730/4885MEN1 3678/4885KMT2A 2963/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.